Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion type Assertion NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_head.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion description "[However, patients heterozygous for MTHFR A1298C or MTR A2756 G genotypes have 1.62- and 2.13-fold higher risk, respectively, of developing bladder cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_provenance.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion evidence source_evidence_literature NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_provenance.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion SIO_000772 19837268 NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_provenance.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion wasDerivedFrom gad-20150221 NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_provenance.
- NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_assertion wasGeneratedBy ECO_0000203 NP158120.RAyvdHXCSwdAJ5wNzMJ-U_Tx1dHC1OJmH7OxCdImCvHVE130_provenance.